AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,200
+1,300 (2.10%)
At close: Apr 27, 2026
287.97%
Market Cap 1.48T
Revenue (ttm) 2.17B
Net Income (ttm) -9.73B
Shares Out 23.34M
EPS (ttm) -429.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 168,793
Average Volume 219,637
Open 62,500
Previous Close 61,900
Day's Range 61,700 - 64,500
52-Week Range 14,710 - 74,000
Beta 1.70
RSI 58.63
Earnings Date n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.